Scripta Therapeutics
PrivateLast Round
Seed
Nov 13, 2025
Total Funding Raised
$12M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Scripta Therapeutics operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was a Seed round in November 2025.
Scripta Therapeutics is a techbio company that develops disease-modifying therapeutics for neurodegenerative disorders by modulating transcription factor activity using an AI-driven, biology-first platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scripta Therapeutics Comparables
Compare Scripta Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Talus Bio | 82% | |
| Unravel Biosciences | 78% | |
| AcuraStem | 76% |
For institutional investors. Book with your work email.
Scripta Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Scripta Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oxford Science Enterprises | Seed |
| YZR Capital | Seed |
| University of Oxford | Seed |
| Oxford University Innovation | Seed |
| Oxford Science Enterprises | Seed |
| YZR Capital | Seed |
| Albion Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 277% MoM.
- Nov 13, 2025
$12M raised in Seed round.
For institutional investors. Book with your work email.
Scripta Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Scripta Therapeutics's valuation, stock price, and market status.
Is Scripta Therapeutics a public or private company?
Scripta Therapeutics is a private company.
What is the current stock price of Scripta Therapeutics?
Scripta Therapeutics is a private company, so its shares have no public market price. Caplight tracks Scripta Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Scripta Therapeutics worth (valuation)?
Valuation information for Scripta Therapeutics is not publicly available.
Can I buy Scripta Therapeutics stock?
Scripta Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Scripta Therapeutics's last funding round?
Scripta Therapeutics's most recent funding round was Seed on November 13, 2025.
Who are the main investors in Scripta Therapeutics?
Key investors in Scripta Therapeutics include Oxford Science Enterprises, Oxford Science Enterprises.
Will Scripta Therapeutics IPO soon?
No public IPO plans have been announced for Scripta Therapeutics.
How can I track Scripta Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Scripta Therapeutics's shares on secondary markets.